Depo-Medrol 40 mg/ml injektionsvæske, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

depo-medrol 40 mg/ml injektionsvæske, suspension

nordic prime aps - methylprednisolonacetat - injektionsvæske, suspension - 40 mg/ml

Diprofos Depot 7 mg/ml injektionsvæske, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diprofos depot 7 mg/ml injektionsvæske, suspension

nordic prime aps - betamethasondinatriumphosphat, betamethasondipropionat - injektionsvæske, suspension - 7 mg/ml

Solu-Cortef 100 mg pulver og solvens til injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

solu-cortef 100 mg pulver og solvens til injektionsvæske, opløsning

2care4 aps - hydrocortisonnatriumsuccinat - pulver og solvens til injektionsvæske, opløsning - 100 mg

Solu-Medrol lactosefri 40 mg pulver og solvens til injektionsv?ske, opl?sning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

solu-medrol lactosefri 40 mg pulver og solvens til injektionsv?ske, opl?sning

pfizer aps - methylprednisolonnatriumsuccinat - pulver og solvens til injektionsvæske, opløsning - 40 mg

Bexsero Den Europæiske Union - dansk - EMA (European Medicines Agency)

bexsero

gsk vaccines s.r.l. - ydre membran vesikler fra neisseria meningitidis gruppe b (stamme nz 98/254), rekombinant neisseria meningitidis gruppe b fhbp fusion protein, rekombinant neisseria meningitidis gruppe b nada protein, rekombinant neisseria meningitidis gruppe b nhba fusion protein - meningitis, meningokok - meningokokvacciner - aktiv immunisering mod invasiv sygdom forårsaget af neisseria meningitidis serogruppe b-stammer.

Flebogamma DIF (previously Flebogammadif) Den Europæiske Union - dansk - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - humant normalt immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immune sera og immunoglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.